Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1996
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996WO1996029605A3 Compounds and methods for the dectection of t. cruzi infection
11/21/1996WO1996029407A3 Cellubrevin homologs
11/21/1996DE19517020A1 Niedermolekularer Wirkstoffextrakt aus Hefen und Verfahren zu seiner Herstellung Low molecular weight substance extract from yeasts and process for its preparation
11/21/1996CA2227326A1 Carbohydrate-mediated coupling of peptides to immunoglobulins
11/21/1996CA2221348A1 Transcriptional control sequences and methods
11/21/1996CA2221305A1 Gene therapy for effector cell regulation
11/21/1996CA2221303A1 Obesity gene product
11/21/1996CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996CA2221232A1 Post-translational activation of tgf-.beta.1 involving the tsp-1 receptor cd36
11/21/1996CA2220674A1 Leptospira membrane proteins
11/21/1996CA2220010A1 Bmp-15 compositions
11/21/1996CA2219984A1 Cell death protein
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996CA2217969A1 Ataxia-telangiectasia gene and its genomic organization
11/21/1996CA2217965A1 Ataxia-telangiectasia gene
11/21/1996CA2217020A1 Recombinant heregulins and their biological functions upon receptor activation
11/20/1996EP0743522A1 Stabilised troponin composition for immunoassays and method for preparing such stabilised compositions
11/20/1996EP0743520A2 Novel uses for GAL4-receptor constructs
11/20/1996EP0743365A2 Process for efficiently producing transglutaminase through DNA recombination
11/20/1996EP0743364A2 Nucleic acid fragments derived form the HIV-1 genome, corresponding fragments and their application as reactives for risk evaluation of HIV-1 mother-foetal transmission
11/20/1996EP0743321A2 Obesity gene product
11/20/1996EP0742903A1 Piperidine analogs and conjugates of procainamide and napa
11/20/1996EP0742902A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/20/1996EP0742831A1 Transgenic non-human mammals with progressive neurologic disease
11/20/1996EP0742830A1 Fusion proteins that include antibody and nonantibody portions
11/20/1996EP0742829A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/20/1996EP0742826A1 Multivariant il-3 hematopoiesis fusion protein
11/20/1996EP0742825A1 Cloning and recombinant production of crf receptor(s)
11/20/1996EP0742824A1 Wd-40-derived peptides and uses thereof
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742822A1 Folding proteins
11/20/1996EP0742820A1 Production of pharmaceutical-grade plasmid dna
11/20/1996EP0742796A1 Il-3 variant hematopoiesis fusion protein
11/20/1996EP0742795A1 Immuno-stimulatory monoclonal antibodies
11/20/1996EP0742794A1 Interleukin-6 (il-6) antagonists
11/20/1996EP0742793A1 Bcl-2-associated proteins
11/20/1996EP0742792A1 Subunits of glutamate receptors, method for producing them and their use
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996EP0742723A1 Homologous recombination for universal donor cells and chimeric mammalian hosts
11/20/1996EP0742721A1 Methods of prolonged suppression of humoral immunity
11/20/1996EP0742720A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
11/20/1996EP0656783B1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin
11/20/1996EP0542895B1 Cross-reactive influenza a immunization
11/20/1996EP0517895B1 Chimeric chains for receptor-associated signal transduction pathways
11/20/1996EP0479916B1 Gamma retinoic acid receptor
11/20/1996EP0439535B1 Cdnas coding for the gamma subunit of the high-affinity receptor for immunoglobulin e
11/20/1996EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/20/1996CN1136328A Analog of haemophilus HIN47 with reduced protease activity
11/20/1996CN1136281A Arteriosclerosis remedy
11/20/1996CN1136280A Anti-aids secretory recombinant BCG vaccine
11/20/1996CN1136043A Human interleukin-6 inhibitor
11/20/1996CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma
11/20/1996CA2175862A1 Propoxyphene derivatives for immunoassay reagents
11/19/1996US5576423 Antibodies to the slam protein expressed on activated T cells
11/19/1996US5576422 MCC protein and antibody
11/19/1996US5576421 Recombinant chimeric HIV-1 Gag-Env fusion proteins
11/19/1996US5576420 Subtilin variant of enhanced stability and activity
11/19/1996US5576419 Mild solid-phase synthesis of aligned branched triple-helical peptides
11/19/1996US5576301 Low molecular growth potentiating peptides
11/19/1996US5576300 Method for inhibition of human rotavirus infection
11/19/1996US5576297 Embodiments of natural and synthetic lethal toxin neutralizing factors and their utility as treatment for envenomation
11/19/1996US5576296 Galanin antagonist
11/19/1996US5576295 Agent for suppressing the motor activity of gastrointestinal tracts
11/19/1996US5576294 Polypeptides as enzyme inhibitors
11/19/1996US5576292 Biologically active bactericidal/permeability-increasing protein fragments
11/19/1996US5576290 Compositions and methods for the diagnosis and treatment of psychogenic erectile dysfunction
11/19/1996US5576210 Mammalian/yeast hybrid G protein-coupled receptors
11/19/1996US5576208 Antisense oligonucleotide inhibition of the RAS gene
11/19/1996US5576206 Human papilloma virus genes and their use in gene therapy
11/19/1996US5576205 Kainate-binding human CNS receptors of the EAA1 family
11/19/1996US5576203 Plants, seeds and process for storage of protein
11/19/1996US5576202 Potato transformed with dna encoding p1 protein of potato virus y
11/19/1996US5576201 Retroviral vector particles for transducing non-proliferating cells
11/19/1996US5576195 Dna coding; preparing immunoglobulins
11/19/1996US5576194 Recombinant protein production
11/19/1996US5576193 Protein having human plasmin inhibiting activity
11/19/1996US5576192 Prostaglandin E receptors, their DNA and production
11/19/1996US5576191 Cytokine that binds ST2
11/19/1996US5576190 Bacteriophage Lambda pL promoters
11/19/1996US5576189 Antibody to type-I collagen amino-terminal telopeptide
11/19/1996US5576179 Method of detecting toxin-insensitive urf13-T protein
11/19/1996US5576175 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
11/19/1996US5576000 Envelope protein of hiv with sequences
11/19/1996CA2096315C Human rotaviruses, vaccines and methods
11/14/1996WO1996035955A1 Method of diagnosing prostate cancer
11/14/1996WO1996035951A1 Novel peptides and compositions which modulate apoptosis
11/14/1996WO1996035813A1 A transition in transcriptional activation by intracellular hormone receptors at the tumor stage of dermal fibrosarcoma development
11/14/1996WO1996035808A1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types
11/14/1996WO1996035804A1 A novel biochemical interaction in bacteria
11/14/1996WO1996035797A1 Hbv vectors and cells for producing the same
11/14/1996WO1996035790A1 Plant pathogen resistance genes and uses thereof
11/14/1996WO1996035789A1 Human interferon tau compositions and methods of use
11/14/1996WO1996035788A2 Kunitz type protease inhibitors
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035786A1 Pearl protein (nacrein) and process for producing the same
11/14/1996WO1996035785A2 Transgenic animals having a defective thyroid hormone receptor beta gene
11/14/1996WO1996035784A2 Chromatin-regulator genes
11/14/1996WO1996035783A1 Methods of preparing soluble, oligomeric proteins
11/14/1996WO1996035782A1 Il-6 activity inhibitor